BCL2 and lymphoma: We treated three lymphoma cell lines, two with t (14;18) and BCL-2 rearrangements (WSU-FSCCL and WSU-DLCL2) and one (WSU-WM) lacking these rearrangements, with different concentrations (2.5μM, 5.0μM, and 10μM) of PNT2258.